By detailed characterization of the cell atlases of these Pkd1 mutant kidneys, our studies have provided novel insights into cell-type specific functions that can power the therapeutic targeting of ADPKD. This evidence concerns the gene PKD1 and autosomal dominant polycystic kidney disease.